Hsp90/C terminal Hsc70-interacting protein regulates the stability of Ikaros in acute myeloid leukemia cells
- 8 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Science China Life Sciences
- Vol. 64 (9), 1481-1490
- https://doi.org/10.1007/s11427-020-1860-2
Abstract
The stability of Ikaros family zinc finger protein 1 (Ikaros), a critical hematopoietic transcription factor, can be regulated by cereblon (CRBN) ubiquitin ligase stimulated by immunomodulatory drugs in multiple myeloma. However, other stabilization mechanisms of Ikaros have yet to be elucidated. In this study, we show that the pharmacologic inhibition or knockdown of Hsp90 downregulates Ikaros in acute myeloid leukemia (AML) cells. Proteasome inhibitor MG132 but not autophagy inhibitor chloroquine could suppress the Hsp90 inhibitor STA-9090-induced reduction of Ikaros, which is accompanied with the increased ubiquitination of Ikaros. Moreover, Ikaros interacts with E3 ubiquitin-ligase C terminal Hsc70 binding protein (CHIP), which mediates the STA-9090-induced ubiquitination of Ikaros. In addition, the knockdown of Ikaros effectively inhibits the proliferation of leukemia cells, but this phenomenon could be rescued by Ikaros overexpression. Collectively, our findings indicate that the interplay between HSP90 and CHIP regulates the stability of Ikaros in AML cells, which provides a novel strategy for AML treatment through targeting the HSP90/Ikaros/CHIP axis.Keywords
This publication has 40 references indexed in Scilit:
- The Making of a Leukemic Stem Cell: A Novel Role for IKZF2 in AML Stemness and DifferentiationCell Stem Cell, 2019
- Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic LeukemiaCancer Cell, 2018
- CHIP: A new modulator of human malignant disordersOncotarget, 2016
- IKAROS: a multifunctional regulator of the polymerase II transcription cycleTrends in Genetics, 2015
- IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951Leukemia, 2015
- The IKAROS Interaction with a Complex Including Chromatin Remodeling and Transcription Elongation Activities Is Required for HematopoiesisPLoS Genetics, 2014
- A Dominant-Negative Isoform of IKAROS Expands Primitive Normal Human Hematopoietic CellsStem Cell Reports, 2014
- The Drug-Induced Degradation of Oncoproteins: An Unexpected Achilles' Heel of Cancer Cells?Cancer Discovery, 2011
- Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemiasBlood, 2010
- The 90-kDa Molecular Chaperone FamilyPharmacology & Therapeutics, 1998